Intracellular IL-1α-binding proteins contribute to biological functions of endogenous IL-1α in systemic sclerosis fibroblasts

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 39, 2006, Pages 14501-14506

  Kawaguchi, Yasushi ^a   Nishimagi, Emi ^a   Tochimoto, Akiko ^a   Kawamoto, Manabu ^a   Katsumata, Yasuhiro ^a   Soejima, Makoto ^a   Kanno, Tokiko ^a   Kamatani, Naoyuki ^a   Hara, Masako ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Collagen; Fibrosis; HS1 associated protein X 1; IL 1 receptor type II; IL 6

Indexed keywords

BINDING PROTEIN; CELL PROTEIN; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 1ALPHA PRECURSOR; INTERLEUKIN 6; PROCOLLAGEN; PROTEIN; PROTEIN HAX 1; PROTEIN PRECURSOR; RECEPTOR SUBTYPE; SULFUR 35; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; HAX1 PROTEIN, HUMAN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR TYPE II; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBROSIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; SEQUENCE HOMOLOGY; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CELL STRAIN 3T3; CYTOLOGY; FEMALE; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM;

ANIMALS; CELL NUCLEUS; CELLS, CULTURED; COLLAGEN TYPE I; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOPRECIPITATION; INTERLEUKIN-1; MICE; MIDDLE AGED; MODELS, BIOLOGICAL; NIH 3T3 CELLS; PROTEIN BINDING; PROTEIN PRECURSORS; PROTEIN TRANSPORT; PROTEINS; RECEPTORS, INTERLEUKIN-1; RECEPTORS, INTERLEUKIN-1 TYPE II; RNA INTERFERENCE; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; SIGNAL TRANSDUCTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 33749243490     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0603545103     Document Type: Article

References (32)

1. Medsger TA, Jr (2001) in Arthritis and Allied Conditions, ed Koopman WJ (Lippincott Williams & Wilkins, Philadelphia), pp 1590-1624.
2. Varga J, Korn JH (2004) in Systemic Sclerosis, eds Clement PJ, Furst DE (Lippincott Williams & Wilkins, Philadelphia), pp 63-97.
3. Kawaguchi Y (1994) Clin Exp Immunol 97:445-450.
4. Kawaguchi Y, Hara M, Wright TM (1999) J Clin Invest 103:1253-1260.
5. Kawaguchi Y, McCarthy SA, Watkins SC, Wright TM (2004) J Rheumatol 31:1946-1954.
6. Dinarello CA (1996) Blood 87:2095-2147.
7. Kobayashi Y, Yamamoto K, Saido T, Kawasaki H, Oppenheim JJ, Matsushima K (1990) Proc Natl Acad Sci USA 87:5548-5552.
8. Wessendorf JHM, Garfinkel S, Zhan X, Brown S, Maciag T (1993) J Biol Chem 268:22100-22104.
9. Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, Grubin CE, Wignall JM, Jackson JL, Call SM, et al. (1988) Science 241:585-589.
10. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G (1995). J Biol Chem 270:13757-13765.
11. Lonnemann G, Engler-Blum G, Muller GA, Koch KM, Dinarello CA (1995) Kidney Int 47:845-854.
12. Maier JAM, Voulalas P, Roeder D, Maciag T (1990) Science 249:1570-1574.
13. Buryskova M, Pospisek M, Grothey A, Simmet T, Burysek L (2004) J Biol Chem 279:4017-4026.
14. Werman A, Werman-Venkert R, White R, Lee J-K, Werman B, Krelin Y, Voronov E, Dinarello CA, Apte RN (2004) Proc Natl Acad Sci USA 101:2434-2439.
15. Stevenson FT, Turck J, Locksley RM, Lovett DH (1997) Proc Natl Acad Sci USA 94:508-513.
16. Yin H, Morioka H, Towle CA, Vidal M, Watanabe T, Weissbach L (2001) Cytokine 15:122-137.
17. McMahon CJ, Slack JL, Mosley B, Cosman D, Lupton SD, Brunton LL, Grubin CE, Wignall JM, Jenkins NA, Brannan CI, et al. (1991) EMBO J 10:2821-2832.
18. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, et al. (1993) Proc Natl Acad Sci USA 90:6155-6159.
19. Suzuki Y, Demoliere C, Kitamura D, Takeshita H, Deuschle U, Watanabe T (1997) J Immunol 158:2736-2744.
20. Taniuchi I, Kitamura D, Maekawa Y, Fukuda T, Kishi H, Watanabe T (1995) EMBO J 14:3664-3678.
21. Yedavalli VSRK, Shih H-M, Chiang Y-P, Lu C-Y, Chang L-Y, Chen M-Y, Chuang C-Y, Dayton AI, Jeang K-T, Huang L-M (2005) J Virol 79:13735-13746.
22. Gallagher AR, Cedzich A, Gretz N, Somlo S, Witzgall R (2000) Proc Natl Acad Sci USA 97:4017-4022.
23. Matsuda G, Nakajima K, Kawaguchi Y, Yamanashi Y, Hirai K (2003) Microbiol Immunol 47:91-99.
24. Beuscher HU, Nickells MW, Colten HR (1988) J Biol Chem 263:4023-4028.
25. Stevenson FT, Bursten SL, Fanton C, Locksley RM, Lovett DH (1993) Proc Natl Acad Sci USA 90:7245-7249.
26. Hu B, Wang S, Zhang Y, Fegahli CA, Dingman JR, Wright TM (2003) Proc Natl Acad Sci USA 100:10008-10013.
27. Hayashi Y, Matsuyama K, Takagi K, Sugiura H, Yoshikawa K (1995) Biochem Biophys Res Commun 213:317-324.
28. Tanimura H, Taniguchi N, Hara M, Yoshikawa K (1998) J Biol Chem 273:720-728.
29. Higgins GC, Wu Y, Postlethwaite AE (1999) J Immunol 163:3969-3975.
30. Kanangat S, Postlethwaite AE, Higgins GC, Hasty KA (2006) J Invest Dermatol 126:756-765.
31. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Arthritis Rheum 23:581-590.
32. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Jr, Rowell N, Wollheim F (1988) J Rheumatol 15:202-205.